Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DiaMedica Therapeutics Inc. - Common Stock
(NQ:
DMAC
)
7.575
-0.965 (-11.30%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DiaMedica Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Provides DM199 Preeclampsia Program Update Following Pre-IND Meeting with FDA
December 18, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 14, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Exploring DiaMedica Therapeutics's Earnings Expectations
↗
August 11, 2025
Via
Benzinga
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress
↗
November 12, 2025
DiaMedica reports Q3 2025 results, advancing DM199 for stroke and preeclampsia. The company has a cash runway into H2 2027 to fund clinical trials.
Via
Chartmill
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
November 12, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
An Overview of DiaMedica Therapeutics's Earnings
↗
November 11, 2025
Via
Benzinga
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
November 10, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
November 06, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 15, 2025
Via
Benzinga
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 29, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
September 02, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 18, 2025
Via
Benzinga
DiaMedica Posts Narrower Loss in Q2
↗
August 12, 2025
Via
The Motley Fool
Topics
Intellectual Property
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
↗
August 12, 2025
DiaMedica Therapeutics reports Q2 2025 results with a narrower-than-expected loss, positive clinical updates, and strong cash position. Stock surges 19% post-earnings.
Via
Chartmill
DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
August 12, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer
August 06, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025
August 05, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement
July 23, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline
July 21, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
July 17, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
June 24, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
May 22, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
May 19, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Poster Presentation at European Stroke Organisation Conference – ESOC 2025
May 14, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
May 13, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For May 13, 2025
↗
May 13, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
